BUHLMANN Debriefing- EuroMedLab 2019

BÜHLMANN Educational Workshop at EuroMedLab 2019

The BÜHLMANN Educational Workshop at EuroMedLab 2019, focused on optimizing workflow for fecal calprotectin testing was a great success.  This workshop offered insightful presentations from three laboratories discussing the process of stool sample pre-analytics and how they worked to find a solution to cope with continuously increasing test numbers. State-of-the-art technologies combined with modern sample management strategies were the key to measure up to the challenge.

BÜHLMANN at EuroMedLab 2019

View videos from the EuroMedLab and the Educational Workshop presented by BÜHLMANN

Introduction Video

Dr. Aleksandra Havelka (Sweden)

Laboratory Workflow Optimization in the Field of Fecal Calprotectin Testing

Dr. Luca Germagnoli (Italy)

Fecal Calprotectin in Modern Clinical Chemistry

Dr. Lukas Bestmann (Switzerland)

Full Automation – The Future Laboratory

Dr. Maurice Redondo (Switzerland)

Highlights from this Presentation

–History of Calprotectin: Short historic summary of calprotectin from discovery to clinical use

–Extraction Procedure: Overview of fecal extraction procedures

–Progression of Testing: Fecal calprotectin from niche to full automation

Highlights from this Presentation

–Challenge: Increasing workload and slow reaction time

–Goal: Reduce Turnaround time (TAT), maintain analytical quality, improve daily workflow

–Solution: Replacement of manual ELISA method, implementation of automated solution: BÜHLMANN fCAL® turbo

Highlights from this Presentation

–Challenge: Increasing demand for calprotectin testing

–Goal: Reduce TAT through automation using random access analyzer

–Solution: Implementation of a convenient fecal extraction method utilizing CALEX® Cap on an automated analyzer simultaneously with other types of specimens and tests, streamlining the workflow, providing speed, efficiency, and extended measuring range

Highlights from this Presentation

–Challenge: To overcome the obstacles experienced in the past with calprotectin tests – i.e. lack of track capabilities coupled with contamination issues, etc.

–Goal: Bring new calprotectin assay on that can be streamlined with all the other sample types in their fully automated lab and can be run 24/7

–Solution: Implementation of  BÜHLMANN fCAL® turbo with CALEX® Cap to be run on their automated, random access analyzer

BÜHLMANN fCAL® turbo (K190784): FDA 510(k) cleared. For in vitro Diagnostic Use.
BÜHLMANN fCAL® turbo + CALEX® Cap (K191718): FDA 510(k) cleared. For in vitro Diagnostic Use.
Health Canada Licenses: BÜHLMANN fCAL® turbo (96808), CALEX® Cap (98839)

BÜHLMANN fCAL® turbo currently has validated application notes for the Roche c501/502 for use in the U.S. Other major chemistry system validation packages are in process. Please contact BUHLMANN Diagnostics Corp for a complete list of validated applications.